Literature DB >> 16311589

ORL1 receptor-mediated internalization of N-type calcium channels.

Christophe Altier1, Houman Khosravani, Rhian M Evans, Shahid Hameed, Jean B Peloquin, Brian A Vartian, Lina Chen, Aaron M Beedle, Stephen S G Ferguson, Alexandre Mezghrani, Stefan J Dubel, Emmanuel Bourinet, John E McRory, Gerald W Zamponi.   

Abstract

The inhibition of N-type calcium channels by opioid receptor like receptor 1 (ORL1) is a key mechanism for controlling the transmission of nociceptive signals. We recently reported that signaling complexes consisting of ORL1 receptors and N-type channels mediate a tonic inhibition of calcium entry. Here we show that prolonged ( approximately 30 min) exposure of ORL1 receptors to their agonist nociceptin triggers an internalization of these signaling complexes into vesicular compartments. This effect is dependent on protein kinase C activation, occurs selectively for N-type channels and cannot be observed with mu-opioid or angiotensin receptors. In expression systems and in rat dorsal root ganglion neurons, the nociceptin-mediated internalization of the channels is accompanied by a significant downregulation of calcium entry, which parallels the selective removal of N-type calcium channels from the plasma membrane. This may provide a new means for long-term regulation of calcium entry in the pain pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16311589     DOI: 10.1038/nn1605

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  71 in total

1.  Subtype-specific reduction of voltage-gated calcium current in medium-sized dorsal root ganglion neurons after painful peripheral nerve injury.

Authors:  J B McCallum; H-E Wu; Q Tang; W-M Kwok; Q H Hogan
Journal:  Neuroscience       Date:  2011-01-28       Impact factor: 3.590

2.  Ca(2+) channel currents of cortical neurons from pure and mixed cultures.

Authors:  Chen Zhou; Aiying Yang; Zhen Chai
Journal:  Cytotechnology       Date:  2011-12-06       Impact factor: 2.058

Review 3.  Trafficking and stability of voltage-gated calcium channels.

Authors:  Brett A Simms; Gerald W Zamponi
Journal:  Cell Mol Life Sci       Date:  2011-10-02       Impact factor: 9.261

Review 4.  Calcium channel functions in pain processing.

Authors:  John Park; Z David Luo
Journal:  Channels (Austin)       Date:  2010-11-01       Impact factor: 2.581

Review 5.  G protein modulation of CaV2 voltage-gated calcium channels.

Authors:  Kevin P M Currie
Journal:  Channels (Austin)       Date:  2010-11-01       Impact factor: 2.581

6.  The Cavβ subunit prevents RFP2-mediated ubiquitination and proteasomal degradation of L-type channels.

Authors:  Christophe Altier; Agustin Garcia-Caballero; Brett Simms; Haitao You; Lina Chen; Jan Walcher; H William Tedford; Tamara Hermosilla; Gerald W Zamponi
Journal:  Nat Neurosci       Date:  2010-12-26       Impact factor: 24.884

7.  Alternative Splicing in Ca(V)2.2 Regulates Neuronal Trafficking via Adaptor Protein Complex-1 Adaptor Protein Motifs.

Authors:  Natsuko Macabuag; Annette C Dolphin
Journal:  J Neurosci       Date:  2015-10-28       Impact factor: 6.167

8.  The molecular basis for T-type Ca2+ channel inhibition by G protein beta2gamma2 subunits.

Authors:  Seth D DePuy; Junlan Yao; Changlong Hu; William McIntire; Isabelle Bidaud; Philippe Lory; Fraydoon Rastinejad; Carlos Gonzalez; James C Garrison; Paula Q Barrett
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-14       Impact factor: 11.205

9.  Inflammation reduces the contribution of N-type calcium channels to primary afferent synaptic transmission onto NK1 receptor-positive lamina I neurons in the rat dorsal horn.

Authors:  Beth K Rycroft; Kristina S Vikman; MacDonald J Christie
Journal:  J Physiol       Date:  2007-02-15       Impact factor: 5.182

10.  ERαΔ4, an ERα splice variant missing exon4, interacts with caveolin-3 and mGluR2/3.

Authors:  Angela M Wong; Alexandra K Scott; Caroline S Johnson; Margaret A Mohr; Melinda Mittelman-Smith; Paul E Micevych
Journal:  J Neuroendocrinol       Date:  2019-05-23       Impact factor: 3.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.